Cargando…
The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the aryl hydrocarbon receptor interacting protein (AIP) gene
INTRODUCTION: Prolactinomas are the most frequent type of pituitary adenoma encountered in clinical practice. Dopamine agonists (DA) like cabergoline typically provide sign/ symptom control, normalize prolactin levels and decrease tumor size in most patients. DA-resistant prolactinomas are infrequen...
Autores principales: | Vroonen, Laurent, Beckers, Albert, Camby, Severine, Cuny, Thomas, Beckers, Pablo, Jaffrain-Rea, Marie-Lise, Cogne, Muriel, Naves, Luciana, Ferriere, Amandine, Romanet, Pauline, Elenkova, Atanaska, Karhu, Auli, Brue, Thierry, Barlier, Anne, Pétrossians, Patrick, Daly, Adrian F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498111/ https://www.ncbi.nlm.nih.gov/pubmed/37711900 http://dx.doi.org/10.3389/fendo.2023.1242588 |
Ejemplares similares
-
AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center
por: Daly, Adrian F, et al.
Publicado: (2019) -
AIP variant causing familial prolactinoma
por: Carty, David M., et al.
Publicado: (2020) -
Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers
por: Georgitsi, M, et al.
Publicado: (2007) -
Pituitary Disease in AIP Mutation-Positive Familial Isolated Pituitary Adenoma (FIPA): A Kindred-Based Overview
por: Bilbao Garay, Ismene, et al.
Publicado: (2020) -
A clinically novel AIP mutation in a patient with a very large, apparently sporadic somatotrope adenoma
por: Salvatori, Roberto, et al.
Publicado: (2014)